Barinthus Biotherapeutics plc (FRA:2AB)
0.6050
-0.0100 (-1.63%)
Last updated: Dec 4, 2025, 8:05 AM CET
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of €25.32 million as of December 5, 2025. Its market cap has decreased by -20.54% in one year.
Market Cap
25.32M
Enterprise Value
-28.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.61
Market Cap Chart
Since April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from 399.28M to 25.32M, a decrease of -93.66%. That is a compound annual growth rate of -45.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 25.24M | -46.22% |
| Dec 31, 2024 | 46.94M | -63.54% |
| Dec 29, 2023 | 128.74M | 56.98% |
| Dec 30, 2022 | 82.01M | -75.93% |
| Dec 31, 2021 | 340.74M | -14.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 97.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.46B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |